Quantcast
Last updated on April 24, 2014 at 17:35 EDT

Latest Medical research Stories

2013-11-19 23:22:53

Cardiovascular Research Center at Icahn School of Medicine at Mount Sinai Report Promising Long-Term Follow-up Results for its Single Dose AAV1/SERCA2a Gene Therapy in Advanced Heart Failure Patients New York, New York (PRWEB) November 19, 2013 Researchers from the Cardiovascular Research Center at Icahn School of Medicine at Mount Sinai reported the long-term benefits of a single dose of their gene therapy AAV1/SERCA2a in advanced heart failure patients on Nov. 19 at the American Heart...

2013-11-18 23:19:19

Reportbuyer.com just published a new market research report: The Top 100 Contract Research Organisations In Western Europe. London (PRWEB) November 18, 2013 It is estimated that clinical development expenditures outsourced by pharmaceutical, medical device and biotechnology companies worldwide in 2012 was approximately Euro 20.6 billion. With greatly developed healthcare and medical systems, highly trained investigators and standardisation across multiple countries, in the form of the...

2013-11-15 08:27:03

Data Demonstrate Long-Term Expression of Functional Nerve Growth Factor in the Brain and Stabilization of Brain Cell Metabolic Activity RICHMOND, Calif., Nov. 15, 2013 /PRNewswire/ -- Sangamo BioSciences, Inc. (NASDAQ: SGMO) announced today the presentation of positive data from the Phase 1 clinical trial of CERE-110 (AAV-NGF), a gene therapy approach designed to deliver nerve growth factor (NGF) for the treatment of Alzheimer's disease (AD). This novel product was developed by Ceregene,...

2013-11-13 23:03:59

Preclinical Testing at Icahn School of Medicine at Mount Sinai Shows SUMO-1 Gene Therapy Shrinks an Enlarged Heart, Improves Heart Function, and Blood Flow New York, NY (PRWEB) November 13, 2013 Researchers at the Cardiovascular Research Center at Icahn School of Medicine at Mount Sinai have successfully tested a powerful gene therapy, delivered directly into the heart, to reverse heart failure in large animal models. The new research study findings, published in November 13 issue of...

2013-11-12 08:34:31

PRINCETON, N.J., Nov. 12, 2013 /PRNewswire/ -- Soligenix, Inc. (OTCQB: SNGX) (Soligenix or the Company), a clinical stage biopharmaceutical company focused on developing products to treat serious inflammatory diseases where there remains an unmet medical need, as well as developing several biodefense vaccines and therapeutics, announced today its financial results for the quarter and nine months ended September 30, 2013. Soligenix's revenues for the quarter and nine months ended were $0.3...

2013-11-08 12:23:40

DUBLIN, November 8, 2013 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/tfh2m9/aptamers_market) has announced the addition of the "Global Aptamers Market Technology Trend Analysis Market Report 2013-2018" [http://www.researchandmarkets.com/research/tfh2m9/aptamers_market ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) The global aptamers market is valued at $287 million in 2013 and is...

2013-11-05 23:30:40

Study Scavenger, the multilingual smartphone app is a powerful tool to enhance recruitment for clinical trials. In just a short time, Study Scavenger has gained national recognition and become a force in clinical trial recruitment efforts. Dix Hills, New York (PRWEB) November 05, 2013 Study Scavenger is a free multilingual clinical trial smartphone app which allows potential research volunteers to access thousands of clinical research studies based on their personal preferences and...

2013-11-04 16:28:06

SAN DIEGO, Nov. 4, 2013 /PRNewswire/ -- Profil® Institute for Clinical Research, Inc., a company providing science-driven early phase diabetes and obesity clinical research, announced today the appointment of Dan Bradbury, Managing Member of BioBrit, LLC and former Amylin Pharmaceutical CEO, to its Board of Directors. Mr. Bradbury joins Profil Institute's current Board Directors Dr. John Amatruda, a pharmaceutical research executive and former Senior Vice President and Head of...

2013-11-01 16:23:36

Transposagen Issued Two Key U.S. Patents Covering Gene Editing Technology and Rat Models of Inflammatory & Autoimmune Disease. LEXINGTON, Ky., Nov. 1, 2013 /PRNewswire-iReach/ -- Transposagen Biopharmaceuticals, Inc., based in Lexington, KY, has announced today the issuing of Patent No. 8,399,643 entitled, "Nucleic Acids Encoding Hyperactive PiggyBac Transposases" on March 19th and Patent No. 8,558,055 entitled, "A Genetically Modified Rat Comprising a Cytokine Gene Disruption and...

2013-10-30 23:26:16

Xtalks presents an exciting live webinar on Thursday, November 7, 2013 at 2:00pm EST (11:00am PST) on RNA Aptamers. Toronto, Canada (PRWEB) October 30, 2013 RNA aptamers are an emerging class of molecules demonstrating significant potential in the diagnosis and treatment of human diseases. RNA aptamers are small, single-stranded RNA molecules that are functionally analogous to antibodies. However, RNA aptamers can be produced by chemical synthesis and their small size, low immunogenicity,...


Latest Medical research Reference Libraries

Bulletin of the World Health Organization
2012-06-04 20:04:03

The Bulletin of the World Health Organization is a public health journal established in 1947 and published monthly by the World Health Organization (WHO). The editor-in-chief is Adetokunbo O. Lucas. The journal aims to offer publish health policy and practice guidance based on the best evidence available, while encouraging closer links between scientific investigation and the art of helping populations to lead healthier lives. Articles are published in English and abstracts are available...

British Journal of Cancer
2012-05-28 10:11:32

The British Journal of Cancer (BJC) is a professional medical journal published biweekly by the Nature Publishing Group (a division of Macmillan Publishers Ltd.) on behalf of Cancer Research UK. It provides a forum for clinicians and scientists to communicate original research findings that have relevance to understanding the etiology of cancer and to improving patient treatment and survival. Papers are published both in print and online. The journal publishes full research papers and...

Disease Models & Mechanisms
2012-05-12 21:51:28

Disease Models & Mechanisms (DMM) is a peer-reviewed open-access biomedical journal published by The Company of Biologists, a UK non-profit publisher of international biological journals, such as Journal of Cell Science and the journal Development. The journal covers the mechanisms, diagnostics and treatment of human disease. The journal publishes original research and review articles, and aims to promote communication between basic researchers, translational researchers and...

Antiviral Chemistry & Chemotherapy
2012-04-25 09:59:26

Antiviral Chemistry & Chemotherapy is a peer-reviewed academic journal published bi-monthly by International Medical Press in London since 1997. When founded in January 1990, it was published by Blackwell Science. The current editor-in-chief is Hugh J. Field of University of Cambridge, UK. The journal publishes primary papers and reviews on all aspects of the preclinical development of antiviral agents, including their chemical synthesis, biochemistry, pharmacology, mode of action and...

More Articles (4 articles) »